FDA OKs Intellipharmaceutics' generic desvenlafaxine; shares up 4%

|About: Intellipharmaceutics I... (IPCI)|By:, SA News Editor

The FDA has approved Intellipharmaceutics' (IPCI +4%) generic version of Pfizer's antidepressant Pristiq (desvenlafaxine) in both 50 mg and 100 mg strengths.

Per Symphony Health Solutions, the U.S. market is ~$268M.

Subscribe for full text news in your inbox